[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.239.251. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
May 28, 2003

Liability for Adverse Events in Direct-to-Consumer Advertising—Reply

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;289(20):2647. doi:10.1001/jama.289.20.2647-a

In Reply: Drs Amundson and Isham raise a useful question on the presentation of performance data. We believe that there is no single correct way to present these data. Although we used a presentation that we expected would be useful to readers, Amundson and Isham's approach may be more useful in demonstrating the magnitude of the problem. A limitation of their approach is that it can be relatively insensitive to progress. If, for example, the number of patients with pneumonia who receive prompt treatment and appropriate antibiotics improves sharply but there is no improvement in immunization rates, their indicator would fail to reflect this improvement.

First Page Preview View Large
First page PDF preview
First page PDF preview
×